1. Home
  2. AVPT vs ANIP Comparison

AVPT vs ANIP Comparison

Compare AVPT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AvePoint Inc.

AVPT

AvePoint Inc.

HOLD

Current Price

$10.01

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$78.51

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVPT
ANIP
Founded
2001
2001
Country
United States
United States
Employees
3443
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
AVPT
ANIP
Price
$10.01
$78.51
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$16.64
$110.00
AVG Volume (30 Days)
1.3M
294.9K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
3.32
Revenue
N/A
$206,547,000.00
Revenue This Year
$25.00
$21.01
Revenue Next Year
$19.63
$17.59
P/E Ratio
$1,348.94
$23.94
Revenue Growth
N/A
2.47
52 Week Low
$8.84
$56.71
52 Week High
$20.25
$99.50

Technical Indicators

Market Signals
Indicator
AVPT
ANIP
Relative Strength Index (RSI) 51.29 53.02
Support Level $9.86 $78.80
Resistance Level $10.40 $83.58
Average True Range (ATR) 0.37 2.41
MACD 0.07 -0.04
Stochastic Oscillator 75.56 46.30

Price Performance

Historical Comparison
AVPT
ANIP

About AVPT AvePoint Inc.

AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: